Effect of heparin-stimulated plasma lipolytic activity on VLDL APO B subclass metabolism in normal subjects

被引:31
作者
Malmström, R
Packard, CJ
Caslake, M
Bedford, D
Stewart, P
Shepherd, J
Taskinen, MR
机构
[1] Univ Helsinki, Cent Hosp, Dept Med, Div Endocrinol & Diabetol, FIN-00290 Helsinki, Finland
[2] Glasgow Royal Infirm, Dept Pathol Biochem, Glasgow G4 0SF, Lanark, Scotland
关键词
stable isotopes; triglyceride; kinetics; free fatty acid; apolipoprotein B;
D O I
10.1016/S0021-9150(99)00153-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Heparin given intravenously enhances lipolysis, although fasting lipids are not markedly altered in long-term administration. In the present study we investigated heparin-induced acute perturbation of VLDL subclass metabolism. Eight men were examined during a control study and during an 8.5 h infusion of heparin. H-2(3)-leucine was used as tracer and kinetic constants derived using a non-steady-state model. Heparin infusion increased both plasma lipoprotein and hepatic lipase activity and raised plasma FFAs two-fold (P < 0.001). The fractional catabolic rate (FCR) of VLDL1 apo B increased on heparin (25.7 +/- 3.2 and 10.8 +/- 1.7 pools/d, heparin vs. control, P < 0.02). The FCR of VLDL2 apo B increased to 12.6 +/- 1.9 pools/d on heparin vs. 8.8 +/- 1.1 pools/d during the control (Ns). Total VLDL apo B production was not significantly changed (824 +/- 45 and 692 +/- 91 mg/d, heparin vs. control. NS). We conclude that during heparin infusion, the catabolism of especially large triglyceride-rich VLDL1 apo B is greatly increased. However, although the FFA levels were high during the heparin study, the production of total VLDL apo B did not rise. These findings are consistent with the known action of heparin on lipoprotein lipase but indicate that acute increase in plasma FFA levels does not lead to a rise in VLDL apo B production. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:381 / 390
页数:10
相关论文
共 41 条
[1]   THE VERY-LOW-DENSITY LIPOPROTEIN RECEPTOR MEDIATES THE CELLULAR CATABOLISM OF LIPOPROTEIN-LIPASE AND UROKINASE-PLASMINOGEN ACTIVATOR INHIBITOR TYPE-I COMPLEXES [J].
ARGRAVES, KM ;
BATTEY, FD ;
MACCALMAN, CD ;
MCCRAE, KR ;
GAFVELS, M ;
KOZARSKY, KF ;
CHAPPELL, DA ;
STRAUSS, JF ;
STRICKLAND, DK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (44) :26550-26557
[3]   LIPOPROTEIN-LIPASE ENHANCES THE BINDING OF CHYLOMICRONS TO LOW-DENSITY-LIPOPROTEIN RECEPTOR-RELATED PROTEIN [J].
BEISIEGEL, U ;
WEBER, W ;
BENGTSSONOLIVECRONA, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (19) :8342-8346
[4]  
Bjorkegren J, 1996, J LIPID RES, V37, P76
[5]  
BOSTROM K, 1988, J BIOL CHEM, V263, P4434
[6]   INTERACTION OF NONESTERIFIED FATTY-ACID AND INSULIN IN CONTROL OF TRIACYLGLYCEROL SECRETION BY HEP-G2 CELLS [J].
BYRNE, CD ;
BRINDLE, NPJ ;
WANG, TWM ;
HALES, CN .
BIOCHEMICAL JOURNAL, 1991, 280 :99-104
[7]  
DASHTI N, 1989, J LIPID RES, V30, P1365
[8]   INFLUENCE OF APOLIPOPROTEIN-E POLYMORPHISM ON APOLIPOPROTEIN-B-100 METABOLISM IN NORMOLIPEMIC SUBJECTS [J].
DEMANT, T ;
BEDFORD, D ;
PACKARD, CJ ;
SHEPHERD, J .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (05) :1490-1501
[9]   Sensitive methods to study human apolipoprotein B metabolism using stable isotope-labeled amino acids [J].
Demant, T ;
Packard, CJ ;
Demmelmair, H ;
Stewart, P ;
Bedynek, A ;
Bedford, D ;
Seidel, D ;
Shepherd, J .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1996, 270 (06) :E1022-E1036
[10]   LONG-TERM MAINTENANCE OF HIGH-RATES OF VERY-LOW-DENSITY-LIPOPROTEIN SECRETION IN HEPATOCYTE CULTURES - A MODEL FOR STUDYING THE DIRECT EFFECTS OF INSULIN AND INSULIN DEFICIENCY INVITRO [J].
DUERDEN, JM ;
BARTLETT, SM ;
GIBBONS, GF .
BIOCHEMICAL JOURNAL, 1989, 263 (03) :937-943